Form 4: Boston Scientific EVP John Bradley Sorenson Reports Stock Transactions

Sentiment:

SEC Form 4


John Bradley Sorenson, EVP of Global Operations at Boston Scientific, reported the vesting of restricted stock units and subsequent tax withholding.

Summary

  • On February 12, 2025, John Bradley Sorenson, EVP of Global Operations at Boston Scientific, reported transactions involving Boston Scientific common stock.
  • Sorenson vested 1,731 restricted stock units, each representing the right to receive one share of Boston Scientific common stock.
  • 530 shares were withheld to cover tax obligations at a price of $105.77 per share.
  • Following these transactions, Sorenson directly owns 25,494 shares of Boston Scientific common stock and 5,193 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine filing related to executive compensation, with no indication of positive or negative sentiment.

Future Outlook

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

Industry Context

Executive stock transactions are a routine part of executive compensation and are closely monitored by investors for insights into management's view of the company's prospects.

Key Dates

DateDescription
02/12/2025Date of stock transaction and vesting of restricted stock units.
02/12/2025First vesting date of restricted stock units.
02/12/2028Expiration date of restricted stock units.
02/14/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.